Redmile Group, LLC
- SEC CIK
- 0001425738
- Latest filing
- Aug 14, 2026
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 14, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 71
- −4 vs. Q3 2021
- Portfolio value
- $4.40B
- −$1.33B (−23.3%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| FATEFate Therapeutics Inc | COM | 12,957,222 | $758.1M | 17.2% | 00.0% | Unchanged | History |
| FOLDAmicus Therapeutics, Inc. | COM | 22,716,086 | $262.4M | 6.0% | +1,916,783+9.2% | Added | History |
| SNCEScience 37 Holdings, Inc. | COM | 19,808,234 | $247.0M | 5.6% | +19,808,234 | New | History |
| ARGXArgenx SE | SPONSORED ADR | 521,643 | $182.7M | 4.2% | −208,939−28.6% | Reduced | History |
| LIVNLivaNova PLC | SHS | 2,057,178 | $179.9M | 4.1% | −133,841−6.1% | Reduced | History |
| KYMRKymera Therapeutics, Inc. | COM | 2,587,730 | $164.3M | 3.7% | −205,978−7.4% | Reduced | History |
| ADCTADC Therapeutics SA | SHS | 7,451,029 | $150.5M | 3.4% | −78,300−1.0% | Reduced | History |
| BEAMBeam Therapeutics Inc. | COM | 1,885,850 | $150.3M | 3.4% | −89,156−4.5% | Reduced | History |
| KRYSKrystal Biotech, Inc. | COM | 1,820,898 | $127.4M | 2.9% | −161,534−8.1% | Reduced | History |
| SKINSkinHealth Systems Inc. | COM CL A | 5,082,805 | $122.8M | 2.8% | −2,400,901−32.1% | Reduced | History |
| REPLReplimune Group, Inc. | COM | 3,866,512 | $104.8M | 2.4% | −211,600−5.2% | Reduced | History |
| ATRAAtara Biotherapeutics, Inc. | COM | 6,437,777 | $101.5M | 2.3% | −28,500−0.4% | Reduced | History |
| IGMSIGM Biosciences, Inc. | COM | 3,334,355 | $97.8M | 2.2% | −91,100−2.7% | Reduced | History |
| NRIXNurix Therapeutics, Inc. | COM | 2,958,284 | $85.6M | 1.9% | −134,793−4.4% | Reduced | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 2,165,586 | $83.7M | 1.9% | −877,712−28.8% | Reduced | History |
| ABSIAbsci Corp | COM | 8,031,094 | $65.9M | 1.5% | 00.0% | Unchanged | History |
| VERVVerve Therapeutics, Inc. | COM | 1,708,536 | $63.0M | 1.4% | −160,494−8.6% | Reduced | History |
| RGNXREGENXBIO Inc. | COM | 1,897,223 | $62.0M | 1.4% | −110,778−5.5% | Reduced | History |
| IMGNImmunoGen, Inc. | COM | 8,258,345 | $61.3M | 1.4% | 00.0% | Unchanged | History |
| SRRKScholar Rock Holding Corp | COM | 2,447,926 | $60.8M | 1.4% | −102,279−4.0% | Reduced | History |
| RPTXRepare Therapeutics Inc. | COM | 2,789,496 | $58.8M | 1.3% | +221,800+8.6% | Added | History |
| NVTAInvitae Corp | COM | 3,805,403 | $58.1M | 1.3% | −1,512,074−28.4% | Reduced | History |
| SGENSeagen Inc. | COM | 371,839 | $57.5M | 1.3% | −215,535−36.7% | Reduced | History |
| STOKStoke Therapeutics, Inc. | COM | 2,246,668 | $53.9M | 1.2% | −135,290−5.7% | Reduced | History |
| UNHUnitedHealth Group Inc | Stock | 104,488 | $52.5M | 1.2% | −16,222−13.4% | Reduced | History |
| ICUIIcu Medical Inc | COM | 219,926 | $52.2M | 1.2% | −2,600−1.2% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 110,289 | $51.1M | 1.2% | −17,213−13.5% | Reduced | History |
| SLGCSomaLogic, Inc. | CLASS A COM | 4,142,770 | $48.2M | 1.1% | +170,500+4.3% | Added | History |
| STTKShattuck Labs, Inc. | COM | 5,619,914 | $47.8M | 1.1% | 00.0% | Unchanged | History |
| AUGXAugmedix, Inc. | COM | 14,380,327 | $45.3M | 1.0% | +14,380,327 | New | History |
| GRTSGritstone bio, Inc. | COM | 3,429,171 | $44.1M | 1.0% | +608,086+21.6% | Added | History |
| PLRXPliant Therapeutics, Inc. | COM | 3,083,501 | $41.6M | 0.9% | 00.0% | Unchanged | History |
| OSHOak Street Health, Inc. | COM | 1,203,619 | $39.9M | 0.9% | −674,901−35.9% | Reduced | History |
| PRTAProthena Corp Public Ltd Co | SHS | 765,675 | $37.8M | 0.9% | −135,816−15.1% | Reduced | History |
| ANNXAnnexon, Inc. | COM | 3,228,917 | $37.1M | 0.8% | −120,268−3.6% | Reduced | History |
| AKROAkero Therapeutics, Inc. | COM | 1,602,285 | $33.9M | 0.8% | −1,085,159−40.4% | Reduced | History |
| TRDAEntrada Therapeutics, Inc. | COM | 1,954,420 | $33.5M | 0.8% | +1,954,420 | New | History |
| NUVBNuvation Bio Inc. | COM CL A | 3,671,009 | $31.2M | 0.7% | −870,000−19.2% | Reduced | History |
| CNCCentene Corp | Stock | 361,139 | $29.8M | 0.7% | +361,139 | New | History |
| STVNStevanato Group S.p.A. | ORD SHS | 1,170,225 | $26.3M | 0.6% | −16,800−1.4% | Reduced | History |
| GMABGenmab A/S | SPONSORED ADS | 661,621 | $26.2M | 0.6% | −458,767−40.9% | Reduced | History |
| ISEEIVERIC bio, Inc. | COM | 1,500,000 | $25.1M | 0.6% | +1,500,000 | New | History |
| STLNStarling Oncology, Inc. | COM | 2,500,000 | $24.4M | 0.6% | +2,500,000 | New | History |
| IMTXImmatics N.V. | SHS | 1,765,692 | $23.7M | 0.5% | −176,200−9.1% | Reduced | History |
| NVRONevro Corp | COM | 270,116 | $21.9M | 0.5% | −272,816−50.2% | Reduced | History |
| ALLKAllakos Inc. | COM | 2,077,875 | $20.3M | 0.5% | −53,921−2.5% | Reduced | History |
| BVSBioventus Inc. | COM CL A | 1,325,139 | $19.2M | 0.4% | −164,717−11.1% | Reduced | History |
| NGNENeurogene Inc. | COM | 3,490,835 | $16.8M | 0.4% | −16,400−0.5% | Reduced | History |
| ALXOAlx Oncology Holdings Inc | COM | 782,097 | $16.8M | 0.4% | −82,338−9.5% | Reduced | History |
| ZGNXZogenix, Inc. | COM NEW | 998,114 | $16.2M | 0.4% | −16,300−1.6% | Reduced | History |
| MDVLMedAvail Holdings, Inc. | COM | 11,075,105 | $15.5M | 0.4% | −649,621−5.5% | Reduced | History |
| LVTXLAVA Therapeutics NV | SHS | 2,816,196 | $15.5M | 0.4% | 00.0% | Unchanged | History |
| TKNOAlpha Teknova, Inc. | COM | 725,000 | $14.8M | 0.3% | 00.0% | Unchanged | History |
| ZYMEZymeworks Inc. | COM | 874,397 | $14.3M | 0.3% | −7,700−0.9% | Reduced | History |
| IVVDInvivyd, Inc. | COM | 1,920,960 | $13.9M | 0.3% | −1,326,000−40.8% | Reduced | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 98,064 | $12.5M | 0.3% | −763,337−88.6% | Reduced | History |
| KLRSKalaris Therapeutics, Inc. | COM | 823,371 | $10.7M | 0.2% | −13,541−1.6% | Reduced | History |
| STXSStereotaxis, Inc. | COM NEW | 1,698,204 | $10.5M | 0.2% | −157,300−8.5% | Reduced | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 2,088,089 | $10.5M | 0.2% | 00.0% | Unchanged | – |
| NGMNGM Biopharmaceuticals Inc | COM | 582,805 | $10.3M | 0.2% | −1,922,313−76.7% | Reduced | History |
| RCELAVITA Medical, Inc. | COM | 672,411 | $8.05M | 0.2% | −673,806−50.1% | Reduced | History |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 664,817 | $6.50M | 0.1% | −3,366,704−83.5% | Reduced | History |
| TCRRTCR2 Therapeutics Inc. | COM | 1,346,058 | $6.27M | 0.1% | −2,470,651−64.7% | Reduced | History |
| AYLAOld Ayala, Inc | COM | 667,816 | $5.68M | 0.1% | 00.0% | Unchanged | History |
| HOOKHOOKIPA Pharma Inc. | COM | 2,385,136 | $5.56M | 0.1% | +540,831+29.3% | Added | History |
| XERSXeris Biopharma Holdings, Inc. | COM | 1,046,587 | $3.07M | 0.1% | −312,238−23.0% | Reduced | History |
| CTSOCytosorbents Corp | COM NEW | 717,244 | $3.00M | 0.1% | −327,190−31.3% | Reduced | History |
| SONXSonendo, Inc. | COM | 498,131 | $2.87M | 0.1% | +498,131 | New | History |
| CABACabaletta Bio, Inc. | COM | 696,377 | $2.64M | 0.1% | 00.0% | Unchanged | History |
| BCELAtreca, Inc. | CL A COM | 800,306 | $2.42M | 0.1% | −369,700−31.6% | Reduced | History |
| EPZMEpizyme, Inc. | COM | 454,475 | $1.14M | <0.1% | −7,004,185−93.9% | Reduced | History |
Sold out since Q3 2021 (11)
Positions held at the end of Q3 2021 that are gone from this filing.
| Security | Class | Shares in Q3 2021 | Value in Q3 2021 | % of portfolio in Q3 2021 | History |
|---|---|---|---|---|---|
| AMEDAmedisys Inc | COM | 150,376 | $22.4M | 0.4% | History |
| Dynamics Special Purpose Cor268010105 | CLASS A COM | 1,924,900 | $19.1M | 0.3% | – |
| LFSTLifeStance Health Group, Inc. | COM | 1,222,408 | $17.7M | 0.3% | History |
| ONEM1Life Healthcare Inc | COM | 600,432 | $12.2M | 0.2% | History |
| PROFProfound Medical Corp. | COM NEW | 787,346 | $11.5M | 0.2% | History |
| Itamar Med Ltd465437101 | SPONSORED ADS | 264,600 | $8.00M | 0.1% | – |
| APREAprea Therapeutics, Inc. | COM | 694,918 | $3.55M | 0.1% | History |
| KAKineta, Inc. | COM | 59,487 | $614.0K | <0.1% | History |
| TCDATricida, Inc. | COM | 54,758 | $254.0K | <0.1% | History |
| SYRSSyros Pharmaceuticals, Inc. | COM | 38,912 | $174.0K | <0.1% | History |
| OVIDOvid Therapeutics Inc. | COM | 40,674 | $137.0K | <0.1% | History |